279 results on '"Shim, Joong Sup"'
Search Results
2. Aurora kinase A inhibition induces synthetic lethality in SMAD4-deficient colorectal cancer cells via spindle assembly checkpoint activation
3. Triptolide sensitizes cancer cells to nucleoside DNA methyltransferase inhibitors through inhibition of DCTPP1-mediated cell-intrinsic resistance
4. Natural products targeting cancer cell dependency
5. Aurora A kinase inhibition compromises its antitumor efficacy by elevating PD-L1 expression
6. Aurora kinase A, a synthetic lethal target for precision cancer medicine
7. BET inhibition induces synthetic lethality in PTEN deficient colorectal cancers via dual action on p21CIP1/WAF1
8. Bromodomain and extra-terminal motif (BET) inhibition is synthetic lethal with loss of SMAD4 in colorectal cancer cells via restoring the loss of MYC repression
9. Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics
10. BET inhibition induces synthetic lethality in PTEN deficient colorectal cancers via dual action on p21CIP1/WAF1
11. BRCA1 deficiency sensitizes breast cancer cells to bromodomain and extra-terminal domain (BET) inhibition
12. Table S1-S9 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
13. Figure S6 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
14. Supplementary figure legends from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
15. Data from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
16. Pharmacological blockade of cholesterol trafficking by cepharanthine in endothelial cells suppresses angiogenesis and tumor growth
17. Synthetic lethality of RB1 and aurora A is driven by stathmin-mediated disruption of microtubule dynamics
18. BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
19. Supplementary Table 1 from Personalized Chemotherapy Profiling Using Cancer Cell Lines from Selectable Mice
20. Supplementary Figure 5 from Personalized Chemotherapy Profiling Using Cancer Cell Lines from Selectable Mice
21. Supplementary Figure 6 from Personalized Chemotherapy Profiling Using Cancer Cell Lines from Selectable Mice
22. Supplementary Figure 4 from Personalized Chemotherapy Profiling Using Cancer Cell Lines from Selectable Mice
23. Supplementary Figures 1-4 from Divergence of Antiangiogenic Activity and Hepatotoxicity of Different Stereoisomers of Itraconazole
24. Supplementary Figure 8 from Personalized Chemotherapy Profiling Using Cancer Cell Lines from Selectable Mice
25. Supplementary Figure 3 from Personalized Chemotherapy Profiling Using Cancer Cell Lines from Selectable Mice
26. Supplementary Figure 2 from Personalized Chemotherapy Profiling Using Cancer Cell Lines from Selectable Mice
27. Supplementary Figure 1 from Personalized Chemotherapy Profiling Using Cancer Cell Lines from Selectable Mice
28. Supplementary Table 2 from Personalized Chemotherapy Profiling Using Cancer Cell Lines from Selectable Mice
29. Supplementary Figure 9 from Personalized Chemotherapy Profiling Using Cancer Cell Lines from Selectable Mice
30. Supplementary Figure 7 from Personalized Chemotherapy Profiling Using Cancer Cell Lines from Selectable Mice
31. Supplementary Methods from Personalized Chemotherapy Profiling Using Cancer Cell Lines from Selectable Mice
32. Aurora A kinase inhibition elevates PD-L1 expression and compromises its anti-tumor efficacy
33. Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells
34. ER translocon inhibitor ipomoeassin F inhibits triple-negative breast cancer growth via blocking ER molecular chaperones
35. MDM2 inhibition is synthetic lethal with PTEN loss in colorectal cancer cells via the p53-dependent mechanism
36. Inhibition of angiogenesis by selective estrogen receptor modulators through blockade of cholesterol trafficking rather than estrogen receptor antagonism
37. Small Activating RNA Modulation of the G Protein‐Coupled Receptor for Cancer Treatment (Adv. Sci. 26/2022)
38. Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells
39. TRIM family proteins: roles in proteostasis and neurodegenerative diseases
40. Existing drugs and their application in drug discovery targeting cancer stem cells
41. Chemical screen identifies FDA-approved drugs and target pathways that induce precocious pancreatic endocrine differentiation
42. Terpestacin Inhibits Tumor Angiogenesis by Targeting UQCRB of Mitochondrial Complex III and Suppressing Hypoxia-induced Reactive Oxygen Species Production and Cellular Oxygen Sensing
43. Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa
44. Author response: Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa
45. Identification of an old antibiotic clofoctol as a novel activator of unfolded protein response pathways and an inhibitor of prostate cancer
46. Plakoglobin is a new target gene of histone deacetylase in human fibrosarcoma HT1080 cells
47. Bromodomain and extra-terminal motif (BET) inhibition is synthetic lethal with loss of SMAD4 in colorectal cancer cells via restoring the loss of MYC repression
48. Ring Expansion Leads to a More Potent Analogue of Ipomoeassin F
49. Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells
50. Selective Inhibition of HER2-Positive Breast Cancer Cells by the HIV Protease Inhibitor Nelfinavir
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.